Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.52 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.48 |
| ▸ | TRIM58 | Q8NG06 | 1/20 | 0.48 |
| ▸ | NT5E | P21589 | 2/20 | 0.47 |
| ▸ | DHODH | Q02127 | 2/20 | 0.47 |
| ▸ | ACP1 | P24666 | 5/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4025363 | 0.96 | ABCG2 (0.48) | ABCG2MAP4K4TRIM58NT5EDHODH | |
| SCHEMBL4023370 | 0.92 | NT5E (0.49) | ABCG2MAP4K4TRIM58NT5EDHODH | |
| SCHEMBL4021555 | 0.89 | NT5E (0.48) | ABCG2MAP4K4TRIM58NT5EDHODH | |
| SCHEMBL4028870 | 0.88 | CYP1A2 (0.47) | ABCG2MAP4K4NT5EDHODHACP1 | |
| SCHEMBL4026944 | 0.87 | CLK4 (0.47) | ABCG2MAP4K4NT5EDHODHACP1 | |
| SCHEMBL4816411 | 0.86 | ABCG2 (0.52) | ABCG2MAP4K4NT5EDHODHACP1 | |
| SCHEMBL4028750 | 0.85 | ABCG2 (0.48) | ABCG2MAP4K4ACP1MAOBMEN1 | |
| SCHEMBL4823113 | 0.85 | ABCG2 (0.48) | ABCG2MAP4K4ACP1MAOBMEN1 | |
| SCHEMBL4032492 | 0.85 | NT5E (0.45) | ABCG2MAP4K4NT5EDHODHACP1 | |
| SCHEMBL4029317 | 0.85 | CLK4 (0.48) | DHODHADORA1MEN1KMT2AADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1339690-B1 | N-TYPE CALCIUM CHANNEL ANTAGONISTS FOR THE TREATMENT OF PAIN | ASTRAZENECA AB (SE) | 2009-01-21 | — | — | EP | disclosed |